The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Induction of pulmonary indoleamine 2,3-dioxygenase by interferon.
Open accessAbstract
Pulmonary indoleamine 2,3-dioxygenase [indoleamine: oxygen 2,3-oxidoreductase(decyclizing)] has been found to be induced (30- to 100-fold) in the mouse after a single intraperitoneal administration of bacterial endotoxin [Yoshida, R. & Hayaishi, O. (1978) Proc. Natl. Acad. Sci. USA 75, 3998-4000] or during in vivo virus infection [Yoshida, R., Urade, Y., Tokuda M. & Hayaishi, O. (1979) Proc. Natl. Acad. Sci. USA 76, 4084-4086]. In the present study, an in vitro system with mouse lung slices was developed in which bacterial endotoxin (5 micrograms/ml)produced an induction (approximately 10-fold) of indoleamine 2,3-dioxygenase. The endotoxin was substituted by interferon from mouse L cells or mouse brain. The pulmonary enzyme activity increased almost linearly for 48 hr after addition of mouse interferon (10(4) units/ml) to lung slices. Interferon from mouse L cells or mouse brain produced a 10- to 15-fold increase in the enzyme activity, whereas that from human leukocytes was all but ineffective. The effect also was observed using highly purified L-cell interferon, prepared by poly(U) affinity column chromatography. When interferon was treated either by heat, alpha-chymotrypsin, or anti-interferon serum, such increase in the enzyme activity was diminished essentially to the same extent as seen in the antiviral activity. The increase in the enzyme activity was blocked when actinomycin D or cycloheximide was added to the slices before interferon treatment. These results suggest that the enzyme induction was produced by interferon and not by possible contaminants in the interferon preparations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis
ROBERTS, W. K., HOVANESSIAN, A., BROWN, R. E., CLEMENS, M. J., & KERR, I. M. (1976) · Nature · doi:10.1038/264477a0 · Cited by 435
Indoleamine 2,3-dioxygenase. Purification and some properties
Shimizu, T., Nomiyama, S., Hirata, F., & Hayaishi, O. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30447-7 · Cited by 367
Self-citationTryptophan Pyrrolase of Rabbit Intestine
Yamamoto, S., & Hayaishi, O. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99420-2 · Cited by 289
Self-citationInterferon: An Inducer of Macrophage Activation by Polyanions
Schultz, R. M., Papamatheakis, J. D., & Chirigos, M. A. (1977) · Science · doi:10.1126/science.877584 · Cited by 273
Lampson, G. P., Tytell, A. A., Field, A. K., Nemes, M. M., & Hilleman, M. R. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.58.2.782 · Cited by 265
Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection.
Yoshida, R., Urade, Y., Tokuda, M., & Hayaishi, O. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.4084 · Cited by 211
Self-citationYoshida, R., & Hayaishi, O. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.3998 · Cited by 181
Self-citationStudies on indoleamine 2,3-dioxygenase. I. Superoxide anion as substrate.
Hirata, F., & Hayaishi, O. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41144-7 · Cited by 169
Self-citationROLE OF INTERFERON IN RECOVERY FROM VIRUS INFECTIONS
Isaacs, A., & Hitchcock, G. (1960) · The Lancet · doi:10.1016/s0140-6736(60)91215-0 · Cited by 107
Cited by
A guide to immunometabolism for immunologists
O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586
Pfefferkorn, E. R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.908 · Cited by 854
Tryptophan and the immune response
Moffett, J. R., & Namboodiri, M. A. (2003) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2003.t01-1-01177.x · Cited by 760
The kynurenine pathway: a finger in every pie
Savitz, J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0414-4 · Cited by 756
HEYES, M. P., SAITO, K., CROWLEY, J. S., DAVIS, L. E., DEMITRACK, M. A., DER, M., DILLING, L. A., ELIA, J., KRUESI, M. J. P., LACKNER, A., et al. (1992) · Brain · doi:10.1093/brain/115.5.1249 · Cited by 680
Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation
Hubbard, T. D., Murray, I. A., & Perdew, G. H. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064246 · Cited by 640
Discovery of IDO1 Inhibitors: From Bench to Bedside
Prendergast, G. C., Malachowski, W. P., DuHadaway, J. B., & Muller, A. J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2285 · Cited by 558
Monitoring tryptophan metabolism in chronic immune activation
Schröcksnadel, K., Wirleitner, B., Winkler, C., & Fuchs, D. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.013 · Cited by 551
Favre, D., Mold, J., Hunt, P. W., Kanwar, B., Loke, P., Seu, L., Barbour, J. D., Lowe, M. M., Jayawardene, A., Aweeka, F., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000632 · Cited by 523
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
Prendergast, G. C., Smith, C., Thomas, S., Mandik-Nayak, L., Laury-Kleintop, L., Metz, R., & Muller, A. J. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-014-1549-4 · Cited by 482
The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability
Schoultz, I., & Keita, Å. V. (2020) · Cells · doi:10.3390/cells9081909 · Cited by 467
Kynurenine is an endothelium-derived relaxing factor produced during inflammation
Wang, Y., Liu, H., McKenzie, G., Witting, P. K., Stasch, J.-P., Hahn, M., Changsirivathanathamrong, D., Wu, B. J., Ball, H. J., Thomas, S. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2092 · Cited by 446
Simultaneous Measurement of Serum Tryptophan and Kynurenine by HPLC,
Widner, B., Werner, E. R., Schennach, H., Wachter, H., & Fuchs, D. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.12.2424 · Cited by 411
Byrne, G. I., Lehmann, L. K., & Landry, G. J. (1986) · Infection and Immunity · doi:10.1128/iai.53.2.347-351.1986 · Cited by 385
Subauste, M. C., Jacoby, D. B., Richards, S. M., & Proud, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118067 · Cited by 385
Wirthgen, E., Hoeflich, A., Rebl, A., & Günther, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01957 · Cited by 378
Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase.
Takikawa, O., Yoshida, R., Kido, R., & Hayaishi, O. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35696-x · Cited by 377
Self-citationTryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target
Sorgdrager, F. J. H., Naudé, P. J. W., Kema, I. P., Nollen, E. A., & Deyn, P. P. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02565 · Cited by 372
Terawaki, S., Chikuma, S., Shibayama, S., Hayashi, T., Yoshida, T., Okazaki, T., & Honjo, T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003208 · Cited by 342
Trial watch: IDO inhibitors in cancer therapy
Vacchelli, E., Aranda, F., Eggermont, A., Sautès-Fridman, C., Tartour, E., Kennedy, E. P., Platten, M., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2014) · OncoImmunology · doi:10.4161/21624011.2014.957994 · Cited by 326
IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development
Smith, C., Chang, M. Y., Parker, K. H., Beury, D. W., DuHadaway, J. B., Flick, H. E., Boulden, J., Sutanto-Ward, E., Soler, A. P., Laury-Kleintop, L. D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0014 · Cited by 322
Induction of Haem Oxygenase as a Defence Against Oxidative Stress
Stocker, R. (1990) · Free Radical Research Communications · doi:10.3109/10715769009148577 · Cited by 322
Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health
Laurans, L., Venteclef, N., Haddad, Y., Chajadine, M., Alzaid, F., Metghalchi, S., Sovran, B., Denis, R. G. P., Dairou, J., Cardellini, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0060-4 · Cited by 300
Reconstructing eukaryotic NAD metabolism
Rongvaux, A., Andris, F., Van Gool, F., & Leo, O. (2003) · BioEssays · doi:10.1002/bies.10297 · Cited by 280
Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2017.07.004 · Cited by 270
Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
Muller, A. J., Manfredi, M. G., Zakharia, Y., & Prendergast, G. C. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-018-0702-0 · Cited by 262
Mithaiwala, M. N., Santana-Coelho, D., Porter, G. A., & O’Connor, J. C. (2021) · Cells · doi:10.3390/cells10061548 · Cited by 190
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
Huang, Y.-S., Ogbechi, J., Clanchy, F. I., Williams, R. O., & Stone, T. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00388 · Cited by 187
Moffett, J. R., Arun, P., Puthillathu, N., Vengilote, R., Ives, J. A., Badawy, A. A.-B., & Namboodiri, A. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00031 · Cited by 89
“An important activator of TDO is cortisol, whereas interferon-γ is one of the more potent inducers of IDO activity (90, 91).”
BackgroundMetabolites Associated With Circulating Interleukin-6 in Older Adults
Lustgarten, M. S., & Fielding, R. A. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw039 · Cited by 44
Metadata
- Authors
- Yoshida, R., Imanishi, J., Oku, T., Kishida, T., & Hayaishi, O.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1981-01
- Volume
- 78
- Issue
- 1
- Pages
- 129-132
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1968651366
- Cited by
- 292
- References
- 14
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.